Ad
related to: novavax
Search results
This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery
247wallst.com· 4 days agoInvesting in biopharmaceutical stocks comes with more risks than some other types of stocks. Take ...
Is Moderna Stock A Buy As Shares Approach Their First Breakout In Over A Year?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
How Often Should Immunocompromised People Get a COVID Booster?
MedPage Today· 1 day agoPreventing SARS-CoV-2 infection in immunocompromised people hasn't gotten any easier as the pandemic...
Analysis finds positive risk-benefit for Novavax COVID vaccine
Center for Infectious Disease Research and Policy· 15 hours agoA drop in overall infections, hospitalizations, and deaths outweighed the risk from rare reports of myocarditis or pericarditis.
Five Keys to Helping Long-COVID Patients Recover
Medscape· 5 days agoAbout 7% of US adults report having or having had symptoms of long COVID such as fatigue, heart palpitations and/or dizziness. While there is no standard...
How Covid killed off a deadly strain of flu
The Telegraph via Yahoo News· 5 days agoThere will also be a knock-on effect for vaccines in development, too. Moderna and Pfizer have quadrivalent mRNA vaccines in phase 3 clinical trials that...
COVID-19: Protecting High-Risk Patients
Medscape· 4 days agoAccess to the latest vaccine should be supported by proactive measures by physicians and health authorities to ensure patients are aware of the risks of...
Ocugen Inc’s (OCGN) Stock: A 61.03% Annual Performance Rate – News Heater
NewsHeater· 1 day agoThe public float for OCGN is 250.87M, and at present, short sellers hold a 14.61% of that float. On March 18, 2024, the average trading volume of OCGN was 5.87M shares. The stock price of Ocugen ...
Is Pfizer Stock A Sell After Two Years In Free Fall? Or Will Seagen Bolster Sales?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 6 days agoAnother concern could be that one of Moderna's programs on the horizon is a combined coronavirus and flu vaccine, but in this space, the company could...